Viatris Inc
General ticker "VTRS" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $15.3B
Viatris Inc follows the US Stock Market performance with the rate: 24.8%.
Estimated limits based on current volatility of 1.5%: low 12.17$, high 12.55$
Factors to consider:
- Company included in S&P500 list
- Company pays dividends: last record date 2024-11-22, amount 0.12$ (Y3.84%)
- Price in estimated range
- Earnings for 18 months up through Q2 (+1 year) are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2022-12-31 to 2024-12-30
- 2022-12-31 to 2023-12-31 estimated range: [8.30$, 13.00$]
- 2023-12-31 to 2024-12-30 estimated range: [8.37$, 13.23$]
Financial Metrics affecting the VTRS estimates:
- Positive: Non-GAAP EPS, $ of 3.34 > 2.29
- Positive: Operating cash flow per share per price, % of 22.11 > 12.76
- Positive: 2.86 < Return on assets ratio (scaled to [-100,100]) of 3.99
- Positive: 9.05 < Operating profit margin, % of 9.93
- Negative: Industry inventory ratio change (median), % of 3.13 > 0.49
Short-term VTRS quotes
Long-term VTRS plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $17,557.10MM | $16,258.30MM | $15,315.30MM |
| Operating Expenses | $17,591.10MM | $14,643.40MM | $14,549.10MM |
| Operating Income | $-34.00MM | $1,614.90MM | $766.20MM |
| Non-Operating Income | $-630.40MM | $1,198.30MM | $-563.30MM |
| Interest Expense | $636.20MM | $592.40MM | $573.10MM |
| R&D Expense | $681.00MM | $662.20MM | $910.70MM |
| Income(Loss) | $-664.40MM | $2,813.20MM | $202.90MM |
| Taxes | $604.70MM | $734.60MM | $148.20MM |
| Profit(Loss) | $-1,269.10MM | $2,078.60MM | $54.70MM |
| Stockholders Equity | $20,492.70MM | $21,072.30MM | $20,467.40MM |
| Inventory | $3,977.70MM | $3,519.50MM | $3,469.70MM |
| Assets | $54,842.80MM | $50,022.20MM | $47,685.50MM |
| Operating Cash Flow | $3,016.90MM | $2,952.60MM | $2,799.60MM |
| Capital expenditure | $509.40MM | $443.00MM | $474.50MM |
| Investing Cash Flow | $-117.80MM | $1,520.50MM | $-764.10MM |
| Financing Cash Flow | $-3,012.00MM | $-3,877.90MM | $-2,301.90MM |
| Earnings Per Share* | $-1.05 | $1.71 | $0.05 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.